Skip to main content
Log in

Peptide histidine valine-42 stimulates gastric acid secretion in man

  • Short Papers
  • Published:
Bioscience Reports

Abstract

The effect of peptide histidine valine-42 (PHV-42) on gastric acid secretion was studied in man. PHV-42 was infused into 5 healthy volunteers at a dose of 10 pmol/kg/min. This dose caused a significant stimulation of basal gastric acid and potassium output. there were no significant changes in circulating gastrin throughout the infusion. In 2 subjects with a background of submaximal pentagastrin stimulation, PHV-42 infusion at the same dose did not alter acid secretion in either subject. The previous observation that PHV-42 is found particularly in the stomach and the new finding that it stimulates basal gastric secretion suggest the possibility that PHV-42 could have a role in local control of acid secretion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Yiangou, Y., Di Marzo, V., Spokes, R. A., Panico, M., Morris, H. R. and Bloom, S. R. (1987) Isolation, characterization, and pharmacological actions of peptide histidine valine 42, a novel prepro-vasoactive intestinal peptide-derived peptide.J. Biol. Chem. 262: 14010–14013.

    PubMed  Google Scholar 

  2. Itoh, N., Obata, K.-i., Yanaihara, N. and Okamoto, H. (1983) Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27,Nature 304:547–549.

    PubMed  Google Scholar 

  3. Yiangou, Y., Christofides, N. D., Blank, M. A., Yanaihara, N., Tatemoto, K., Bishop, A. E., Polak, J. M. and Bloom, S. R. (1985) Molecular forms of peptide histidine isoleucine-like immunoreactivity in the gastrointestinal tract.Gastroenterology 89:516–524.

    PubMed  Google Scholar 

  4. Yiangou, Y., Requejo, F., Polak, J. M. and Bloom, S. R. (1986) Characterisation of a novel prepro VIP derived peptide.Biochem. Biophys. Res. Commun. 139:1142–1149.

    PubMed  Google Scholar 

  5. McGregor, G. P., Bishop, A. E., Blank, M. A., Christofides, N. D., Yiangou, Y., Polak, J. M. and Bloom, S. R. (1984) Comparative distribution of vasoactive intestinal polypeptide (VIP), substance P and PHI in the enteric sphincters of the cat.Experientia 40:469–471.

    PubMed  Google Scholar 

  6. Fahrenkrug, J., Bek, T., Lundberg, J. M. and Hökfelt, T. (1985) VIP and PHI in cat neurons: co-localization but variable tissue content possibly due to differential processing.Regul. Pept. 12:21–34.

    PubMed  Google Scholar 

  7. Yiangou, Y., Williams, S. J., Bishop, A. E., Polak, J. M. and Bloom, S. R. (1987) Peptide histidine-methionine immunoreactivity in plasma and tissue from patients with vasoactive intestinal peptide-secreting tumors and watery diarrhoea syndrome.J. Clin. Endocrinol. Metab. 64:131–139.

    PubMed  Google Scholar 

  8. Bryant, M. G. and Adrian, T. E. (1982) Gastrin. In:Radioimmunoassay of gut regulatory peptides. (Bloom, S. R. and Long, R. G., Eds), W. B. Saunders Company Ltd., London, pp. 51–59.

    Google Scholar 

  9. Makhlouf, G. M. (1974) The neuroendocrine design of the gut. The play of chemicals in a chemical playground.Gastroenterology 67:159–184.

    PubMed  Google Scholar 

  10. Jurrouse, C., Niel, H., Audousset-Puech, M.-P., Martinez, J. and Bataille, D. (1986) Oxyntomodulin and its C-terminal octapeptide inhibit liquid meal-stimulated acid secretion.Peptides 7:Suppl. 1, 253–256.

    Google Scholar 

  11. Holm-Bentzen, M., Christiansen, J., Petersen, B., Fahrenkrug, J., Schultz, A. and Kirkegaard, P. (1981) Infusion of vasoactive intestinal polypeptide in man: Pharmacokinetics and effect on gastric acid secretion.Scand. J. Gastroenterol. 16:429–432.

    Google Scholar 

  12. Holm-Bentzen, M., Christiansen, J., Kirkegaard, P., Stor Olsen, P., Petersen, B. and Fahrenkrug, J. (1983) The effect of vasoactive intestinal polypeptide on meal-stimulated gastric acid secretion in man.Scand. J. Gastroenterol. 18:659–661.

    PubMed  Google Scholar 

  13. Bataille, D., Gespach, M., Laburthe, M., Amiranoff, B., Tatemoto, K., Vauclin, N., Mutt, V. and Rosselin, G. (1980) Porcine peptide having N-terminal histidine and C-terminal isoleucine amide (PHI). Vasoactive intestinal peptide (VIP) and secretin-like effects in different tissues from the rat.FEBS Lett. 114:240–242.

    PubMed  Google Scholar 

  14. Vagne, M., Konturek, S. J. and Chayvialle, J. A. (1982) Effect of vasoactive intestinal peptide on gastric secretion in the cat.Gastroenterology 83:250–255.

    PubMed  Google Scholar 

  15. Makhlouf, G. M. and Said, S. I. (1975) The effect of vasoactive intestinal peptide (VIP) on digestive and hormonal function. In:Gastrointestinal Hormones. (Thompson, J. C., Ed.), University of Texas Press, Austin and London, pp. 599–610.

    Google Scholar 

  16. Judge, D. M., Demers, L. M., Nahrwold, D. L., Dickman, P. S., Petrokubi, R. J. and Trapudki, S. (1977) Vasoactive intestinal polypeptide and gastrin-producing islet cell carcinoma.Arch. Pathol. Lab. Med. 101:262–265.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nikou, G.C., Yiangou, Y., Chrysanthou, B.J. et al. Peptide histidine valine-42 stimulates gastric acid secretion in man. Biosci Rep 9, 369–374 (1989). https://doi.org/10.1007/BF01114690

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01114690

Key Words

Navigation